ArticleArchives of microbiology2026
Host-derived Bacillus velezensis enhances intestinal structure, antioxidant capacity, and pathogen resistance in the American bullfrog (Aquarana catesbeiana).
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The development of host-derived probiotics presents a forward-looking nutritional component strategy for sustainable aquaculture. However, research on host-associated probiotics for the globally farmed American bullfrog (Aquarana catesbeiana) is limited. The research put Bacillus velezensis (BLS) isolated from bullfrog guts determine its probiotic potential. Bullfrogs were divided into two groups: one fed a control diet and the other fed a diet enriched with 1 × 10⁸ CFU/g BLS for 7 weeks. BLS supplementation significantly enhanced growth performance and markedly decreased mortality after challenge with Streptococcus agalactiae. Relative to controls, the BLS cohort demonstrated heightened activity of essential antioxidant enzymes (CAT, GSH-Px, and SOD) and lower malondialdehyde levels in liver and intestinal tissues. Moreover, BLS supplementation enhanced intestinal structure, demonstrated by markedly increased villus height and goblet cell count, alongside enhanced hepatocyte arrangement and tissue integrity. Gut microbiome analysis revealed that BLS elevated the proportion of Firmicutes while decreasing the proportion of harmful genera such as Elizabethkingia. These findings suggest that the probiotic effects are mediated through the modulation of gut barrier function and microbial community. In conclusion, dietary supplementation with B. velezensis BLS enhanced growth, pathogen resistance, antioxidant capacity, and bowel health in bullfrogs through enhanced intestinal morphology and microbiome regulation. Consequently, supplementation holds significant promise as a probiotic in bullfrog farming.
Indexed as
Identifiers
42043591What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.